Evidence map›Paper›PMID 40351310›Full record

ArticleFrontiers in microbiology2025

Characterization of mycobacteria isolated from the Brazilian Atlantic Forest: a public health and bioprospection perspective.

Leandro Santiago Emmerick, Marcos Gustavo Araujo Schwarz, Paloma Rezende Corrêa, Sindy Licette Piñero, Leonardo Henrique Ferreira Gomes, Ana Maria Mazotto Almeida, Richard Hemmi Valente, Wim Maurits Sylvain Degrave, Leila Mendonça-Lima

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Leandro Santiago EmmerickLaboratório de Genômica Aplicada e Bioinovações, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Marcos Gustavo Araujo SchwarzLaboratório de Biologia Molecular Aplicada à Micobactérias, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Paloma Rezende CorrêaLaboratório de Biologia Molecular Aplicada à Micobactérias, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Sindy Licette PiñeroLaboratório de Genômica Aplicada e Bioinovações, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Leonardo Henrique Ferreira GomesLaboratório de Alta Complexidade, Unidade de Pesquisa Clínica, Instituto Fernandes Figueira, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Ana Maria Mazotto AlmeidaLaboratório de Biocatálise Microbiana, Instituto de Microbiologia Paulo de Góes, Federal University of Rio de Janeiro, Cidade Universitária, Rio de Janeiro, Brazil.
Richard Hemmi ValenteLaboratório de Toxinologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Wim Maurits Sylvain DegraveLaboratório de Genômica Aplicada e Bioinovações, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Leila Mendonça-LimaLaboratório de Biologia Molecular Aplicada à Micobactérias, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Mycobacterium genus remains highly relevant today due to the rising incidence of tuberculosis and opportunistic infections caused by environmental mycobacteria. While much is known about

Indexed as

Brazilian Atlantic Forestcellulasemycobacterium shared antigensnontuberculous mycobacteriaprotease

Identifiers

PMID40351310
PMCPMC12062998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.